The field of gene therapy is in great need for well characterized AAV reference materials.
Recombinant adeno-associated virus (rAAV) is a widely used gene delivery tool for research and clinical applications.
Per January 2020 FDA’s gene therapy CMC guidance, commercially sourced, well-characterized AAV reference materials are one of the reference materials for gene therapy.
Vigene’s AAV reference materials (full capsids) with accurate vector genome concentration can be used in qPCR-based vector genome quantification.
Additionally Vigene’s AAV reference materials are well characterized for full-to-empty capsid ratio.
We can provide AAV reference materials in AAV1, AAV2, AAV5, AAV6, AAV8 and AAV9 serotypes.
AAV is known to produce empty particles without payloads.
AAV reference materials (empty capsids) are well characterized AAV empty viral particles.
High quality and high purity AAV reference materials (empty capsids) can be used as controls and standard materials in assays, including HPLC, ELISA, etc.
We offer these AAV reference materials in AAV1, AAV2, AAV5, AAV6, AAV8 and AAV9 serotypes.
- AAV Reference Materials (Full Capsids)
- AAV Reference Materials (Empty Capsids)